Dizal (Jiangsu) Pharmaceutical Co., Ltd. 688192.SS Stock
Dizal (Jiangsu) Pharmaceutical Co., Ltd. Price Chart
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 688192.SS Financial and Trading Overview
Contents
- Dizal (Jiangsu) Pharmaceutical Co., Ltd. Price Chart
- Dizal (Jiangsu) Pharmaceutical Co., Ltd. 688192.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Q&A For Dizal (Jiangsu) Pharmaceutical Co., Ltd. Stock
| Dizal (Jiangsu) Pharmaceutical Co., Ltd. stock price | 39.71 CNY |
| Previous Close | 37.5 CNY |
| Open | 37.6 CNY |
| Bid | 37.27 CNY x N/A |
| Ask | 37.34 CNY x N/A |
| Day's Range | 37.09 - 38.03 CNY |
| 52 Week Range | 24.23 - 56.12 CNY |
| Volume | 827.57K CNY |
| Avg. Volume | 989.74K CNY |
| Market Cap | 15.24B CNY |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.59 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 52.26 CNY |
688192.SS Valuation Measures
| Enterprise Value | 14.41B CNY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 9.701144 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -17.718 |
Trading Information
Dizal (Jiangsu) Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 52.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 56.12 CNY |
| 52 Week Low | 24.23 CNY |
| 50-Day Moving Average | 46.75 CNY |
| 200-Day Moving Average | 41.95 CNY |
688192.SS Share Statistics
| Avg. Volume (3 month) | 989.74K CNY |
| Avg. Daily Volume (10-Days) | 1.08M CNY |
| Shares Outstanding | 408.15M |
| Float | 94.23M |
| Short Ratio | N/A |
| % Held by Insiders | 54.75% |
| % Held by Institutions | 36.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.94% |
| Return on Equity (ttm) | -41.16% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -813110720 CNY |
| Net Income Avi to Common (ttm) | -793800000 CNY |
| Diluted EPS (ttm) | -1.87 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.2B CNY |
| Total Cash Per Share (mrq) | 2.94 CNY |
| Total Debt (mrq) | 76.42M CNY |
| Total Debt/Equity (mrq) | 4.87 CNY |
| Current Ratio (mrq) | 5.383 |
| Book Value Per Share (mrq) | 3.848 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -633696576 CNY |
| Levered Free Cash Flow (ttm) | -533663328 CNY |
Profile of Dizal (Jiangsu) Pharmaceutical Co., Ltd.
| Country | China |
| State | N/A |
| City | Shanghai |
| Address | 199 Liangjing Rd |
| ZIP | 201203 |
| Phone | 86 21 6109 7800 |
| Website | https://www.dizalpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 328 |
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases. It develops Golidocitnib, which is in Phase II clinical trials for the treatment of hematological malignancy and immunological diseases; DZD8586 that is in Phase I for the treatment of hematological malignancy; Sunvozertinib, which is in Phase II clinical trials for the treatment of solid tumors; DZD1516 that is in Phase II clinical trials for the treatment of solid tumors; and DZD2269, which is in Phase I clinical trials for the treatment of solid tumors. The company was founded in 2017 and is based in Shanghai, China.
Q&A For Dizal (Jiangsu) Pharmaceutical Co., Ltd. Stock
What is a current 688192.SS stock price?
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 688192.SS stock price today per share is 39.71 CNY.
How to purchase Dizal (Jiangsu) Pharmaceutical Co., Ltd. stock?
You can buy 688192.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dizal (Jiangsu) Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Dizal (Jiangsu) Pharmaceutical Co., Ltd. is 688192.SS.
Which industry does the Dizal (Jiangsu) Pharmaceutical Co., Ltd. company belong to?
The Dizal (Jiangsu) Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dizal (Jiangsu) Pharmaceutical Co., Ltd. have in circulation?
The max supply of Dizal (Jiangsu) Pharmaceutical Co., Ltd. shares is 415.65M.
What is Dizal (Jiangsu) Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Dizal (Jiangsu) Pharmaceutical Co., Ltd. PE Ratio is now.
What was Dizal (Jiangsu) Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Dizal (Jiangsu) Pharmaceutical Co., Ltd. EPS is -2.59 CNY over the trailing 12 months.
Which sector does the Dizal (Jiangsu) Pharmaceutical Co., Ltd. company belong to?
The Dizal (Jiangsu) Pharmaceutical Co., Ltd. sector is Healthcare.